Mr. Rich is Senior Director of Governance, Grants and Policies in the Innovations Office of the Cleveland Clinic. Experienced commercialization executive, board member and corporate officer with proven success leading diverse, professional teams to achieve vision and results driven financial and strategic objectives. He has hands-on experience in developing and implementing strategic plans, budgets, financial
Dr. Chan is an accomplished entrepreneur and biotechnology executive. He is a cofounder and CSO of NovoMedix, LLC and has over 30 years of experience in drug discovery and development to running clinical trials as well as building and financing start-up companies through private, public and non-dilutive capital markets. He was also the cofounder and
Tony has co-founded and served as Vice President or President of eight different biotechnology companies. As an executive for these companies, he led four translational programs resulting in clinical trials, including the release into the marketplace of a medical food, SulfzixTM, for heart failure. He has initiated multiple licenses, oversaw build-out of facilities, hired staff